✦ LIBER ✦

Hypofractionated–Intensity Modulated Radiation Therapy (Hypo-IMRT) and Temozolomide (TMZ) With and Without Bevacizumab (BEV) for Glioblastoma Multiforme (GBM): A Comparison of 2 Prospective Phase 2 Trials

✍ Scribed by Carlson, J.A.; Reddy, K.; Gaspar, L.E.; Ney, D.; Kavanagh, B.D.; Damek, D.; Lillehei, K.O.; Chen, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a Phase 2 Clinical Trial of N

✍ Shenouda, G.; Souhami, L.; Panet-Raymond, V.; Abdulkarim, B.; Cury, F.; Owen, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB

A Phase 2 Study of Postoperative Intensi

✍ Viswanathan, A.N.; Moughan, J.; Miller, B.E.; Xiao, Y.; Matulonis, U.A.; Horowit 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 63 KB